Back to News
Market Impact: 0.18
Does Silence Therapeutics (SLN) Have the Potential to Rally 82.84% as Wall Street Analysts Expect?
Source: zacks.com
Analyst EstimatesAnalyst InsightsHealthcare & Biotech
Consensus price targets imply 82.8% upside potential for Silence Therapeutics (SLN), but the article cautions that this metric has limited predictive value. An upward trend in earnings estimate revisions may support near-term upside; no realized stock move or specific target price is reported.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
SLN0.20
More News
- Elon Musk says Tesla and SpaceX are weighing a $3.5 trillion merger—without him in the room
- Tesla supplier CATL shares plunge after disappointing Q3 results
- Why is Contemporary Amperex Technology stock sliding today?
- Capital One's strong quarter and progressing Discover integration are rewarded on Wall Street
- Netflix Sales Growth to Decline for Fourth Quarter in a Row
- SpaceX Earnings Blow Past Wall Street Estimates